- Investing Ideas
- Swedish Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Swedish Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
2
0 new
High return on equity, past performance and sound balance sheet.
2 companies
BioGaia
Market Cap: SEK 11.6b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 114.70
7D
1.4%
1Y
16.2%
Bonesupport Holding
Market Cap: SEK 15.0b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 228.00
7D
1.6%
1Y
-20.7%